Bullish Prabhudas Lilladher Recommends Buying HealthCare Global Enterprises
Key Findings
Prabhudas Lilladher, a leading financial services firm, has released a research report highly optimistic about HealthCare Global Enterprises (HealthCare Global). They recommend a "buy" rating for the stock, citing several compelling factors.
Quarterly Performance Highlights
HealthCare Global's recent first-quarter consolidated earnings before interest, taxes, depreciation, and amortization (EBITDA) saw a significant 22% year-over-year increase, amounting to Rs 909 million. However, the company experienced a 1% decline quarter-over-quarter.
Prabhudas Lilladher believes that HealthCare Global is well-positioned for continued growth in the coming years. They have set a target price of Rs 420 per share, valuing the company at 16 times its estimated enterprise value to EBITDA (EV/EBITDA) for the fiscal year ending 2026.
تعليقات